Clinical Trials Logo
  1. Home
  2. Neuromuscular Blockade
  3. NCT03086915
  4. Details
NCT03086915 Clinical Trial

Myorelaxation Practice in Paediatric Anesthesia

Neuromuscular Blockade Clinical Trial

— PAMPE  

Official title:
Myorelaxation Practice in Paediatric Anesthesia: Retrospective Study

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT03086915
Other study ID # KDAR FN Brno 3/2017
Secondary ID
Status Completed
Phase
First received
Last updated
Start date March 5, 2017
Est. completion date August 1, 2017

Study information
Verified date November 2018
Source Brno University Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

In retrospective data search the investigators will identified the percentage of patients with muscle relaxants administered during perioperative period. The block reversal, typ of drug, percentage of cases with and without reversal will be identified.

Description:

The actual percentage of surgeries with the muscle relaxants administered during perioperative period in paediatric patients remain unclear because many surgeries are being performed without muscle relaxation. In this retrospective study, the anesthesiology perioperative data from January 2016 till December 2016 in the tertiary center od Pediatric anesthesia will be searched for the percentage of surgeries with muscle relaxants administered. Type of surgery, age, weight, duration u surgery, muscle relaxants drug and percentage of block reversal will be identified.

Recruitment information / eligibility
Status Completed
Enrollment 1650
Est. completion date August 1, 2017
Est. primary completion date July 30, 2017
Accepts healthy volunteers
Gender All
Age group N/A to 20 Years
Eligibility Inclusion Criteria:

- paediatric patients

- the study period (1/2016-12/2016)

- neuromuscular blocking agent administration during surgery

Exclusion Criteria:

- surgery without neuromuscular blockade

Study Design

Related Conditions & MeSH terms

Intervention

Drug:
• Neuromuscular Blocking Agent
Administration of neuromuscular blockers during anesthesia

Locations
Country Name City State
Czechia Brno University Hospital Brno

Sponsors (2)
Lead Sponsor Collaborator
Brno University Hospital Faculty of medicine, Masaryk University Brno

Country where clinical trial is conducted

Czechia, 

Outcome
Type Measure Description Time frame Safety issue
Primary Percentage of neuromuscular block reversal The actual percentage of paediatric patients with perioperative neuromuscular blockade with active pharmacology block reversal at the end of surgery 1 year
Secondary Percentage of surgeries without muscle relaxant administration Paediatric surgeries without neuromuscular blocking agent administration 1 year
Secondary Type of neuromuscular blocking agent in paediatric anesthesiology practice Actual type of neuromuscular blocking agent used in paediatric anesthesiology practice in predefined period. 1 year
See also
  Status Clinical Trial Phase
Recruiting NCT05558969 - The Effect of Magnesium Use in Reversal of Neuromuscular Block With Sugammadex N/A
Completed NCT03168308 - Sugammadex vs. Neostigmine for Neuromuscular Blockade Reversal in Thoracic Surgical Patients Phase 4
Not yet recruiting NCT03978780 - Erector Spinae Block vs. Placebo Block Study N/A
Completed NCT02892045 - Mindray Neuromuscular Transmission Transducer
Completed NCT02912039 - Electromyographic Assessment of the TetraGraph in Normal Volunteers
Completed NCT03427385 - Minimum Local Anesthetic Dose for Adductor Canal Block N/A
Completed NCT01450813 - The Effect of Neuromuscular Blockade on the Composite Variability Index (CVI) During Laryngoscopy N/A
Completed NCT00535496 - Relation Between TOF-Watch® SX and a Peripheral Nerve Stimulator After 4.0 mg.Kg-1 Sugammadex (P05698) Phase 3
Recruiting NCT05794503 - Postoperative Urinary Retention After Reversal of Neuromuscular Block by Neostigmine Versus Sugammadex Early Phase 1
Not yet recruiting NCT05993390 - Pharmacological Reversal of Neuromuscular Blockade in Critically Ill Patients N/A
Recruiting NCT04609410 - Bleeding in Laparoscopic Liver Surgery N/A
Terminated NCT03649672 - The Validity and Tolerability of Awake Calibration of the TOF Watch SX Monitor N/A
Completed NCT05687253 - Evaluation of Intubation Conditions Following BX1000 or Rocuronium in Subjects Undergoing Surgery Phase 2
Completed NCT05474638 - Comparison of Mechanomyographic 100 Versus 200 Hz 5 Second Tetanic Fade Ratios During Neuromuscular Block Recovery N/A
Completed NCT05120999 - Comparison of Onset of Neuromuscular Blockade With Electromyographic and Acceleromyographic Monitoring
Completed NCT03608436 - The Effect of Low Pressure Pneumoperitoneum During Laparoscopic Colorectal Surgery on Early Quality of Recovery Phase 4
Completed NCT03572413 - The Effect of Low Pressure Pneumoperitoneum During Laparoscopic Colorectal Surgery on Innate Immune Homeostasis. Phase 4
Recruiting NCT02930629 - Residual Block in Postoperative Anaesthetic Care Unit N/A
Completed NCT02932254 - Magnesium Sulfate Effect Following the Reversal of Neuromuscular Blockade Induced by Rocuronium With Sugammadex Phase 4
Completed NCT01828385 - Effect of Magnesium on the Recovery Time of Neuromuscular Blockade With Sugammadex Phase 4

External Links